133 related articles for article (PubMed ID: 1109796)
1. A role for the macrophage in in vivo and in vitro resistance to murine bladder tumor cell growth.
Droller MJ; Remington JS
Cancer Res; 1975 Jan; 35(1):49-53. PubMed ID: 1109796
[TBL] [Abstract][Full Text] [Related]
2. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
Gordon WC; Prager MD
Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
[TBL] [Abstract][Full Text] [Related]
3. Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice.
Fujii T; Igarashi T; Kishimoto S
J Natl Cancer Inst; 1987 Mar; 78(3):509-17. PubMed ID: 2950265
[TBL] [Abstract][Full Text] [Related]
4. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
Vilien M
Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
[No Abstract] [Full Text] [Related]
5. The role of activated macrophages in specific and nonspecific cytostasis of tumor cells.
Krahenbuhl JL; Remington JS
J Immunol; 1974 Aug; 113(2):507-16. PubMed ID: 4210882
[No Abstract] [Full Text] [Related]
6. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
Gabizon A; Leibovich SJ; Goldman R
J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
[TBL] [Abstract][Full Text] [Related]
7. CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells.
Hakim FT; Gazzinelli RT; Denkers E; Hieny S; Shearer GM; Sher A
J Immunol; 1991 Oct; 147(7):2310-6. PubMed ID: 1918963
[TBL] [Abstract][Full Text] [Related]
8. Antigen-specific (p30) mouse CD8+ T cells are cytotoxic against Toxoplasma gondii-infected peritoneal macrophages.
Kasper LH; Khan IA; Ely KH; Buelow R; Boothroyd JC
J Immunol; 1992 Mar; 148(5):1493-8. PubMed ID: 1538132
[TBL] [Abstract][Full Text] [Related]
9. In vitro generation of cytotoxic lymphocytes by tumor extracts of transitional cell carcinoma.
Morales A
Natl Cancer Inst Monogr; 1978 Dec; (49):173-4. PubMed ID: 748769
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the involvement of cytolytic macrophages in rejection of SV40-induced tumors.
Chapes SK; Gooding LR
J Immunol; 1985 Sep; 135(3):2192-8. PubMed ID: 2991384
[TBL] [Abstract][Full Text] [Related]
11. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
Loskog A; Tötterman TH; Böhle A; Brandau S
Cancer Gene Ther; 2002 Oct; 9(10):846-53. PubMed ID: 12224026
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of murine sarcoma by adoptive transfer of resident peritoneal macrophages proliferating in culture.
Bartholeyns J; Lombard Y; Poindron P
Anticancer Res; 1988; 8(1):145-51. PubMed ID: 3358630
[TBL] [Abstract][Full Text] [Related]
13. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
Yoshida R; Yoneda Y; Kuriyama M; Kubota T
J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
[TBL] [Abstract][Full Text] [Related]
14. Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. II. Enhancement of in vitro cell-mediated cytotoxicity by combined chemotherapy-immunotherapy.
Adler A; Keisari Y; Ofir R
J Natl Cancer Inst; 1985 Feb; 74(2):429-36. PubMed ID: 3856051
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of cancer: experimental approach with activated macrophages proliferating in culture.
Bartholeyns J; Lombard Y; Dumont S; Hartmann D; Chokry M; Giaimis J; Kaufmann S; Poindron P
Cancer Detect Prev; 1988; 12(1-6):413-20. PubMed ID: 3180139
[TBL] [Abstract][Full Text] [Related]
16. The role of macrophages in the cytotoxic killing of tumour cells in vitro. I. Primary immunization of lymphocytes in vitro for target cell killing and the mechanism of lymphocyte-macrophage cooperation.
Zembala M; Ptak W; Hanczakowska M
Immunology; 1973 Oct; 25(4):631-44. PubMed ID: 4356674
[TBL] [Abstract][Full Text] [Related]
17. Tumor cytokinetics in the presence of normal, alloimmune, or Bacillus Calmette-Guérin-activated host cells simultaneously assayed in vivo and in vitro.
Normann SJ; Cornelius J
Cancer Res; 1987 Apr; 47(8):2067-72. PubMed ID: 3828996
[TBL] [Abstract][Full Text] [Related]
18. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
James SL; Lazdins JK; Hieny S; Natovitz P
J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456
[TBL] [Abstract][Full Text] [Related]
19. [Cytotoxic lymphocytes and anti-tumor immunity].
Cerottini JC; Brunner KT
Ann Inst Pasteur (Paris); 1972 Apr; 122(4):659-68. PubMed ID: 4403239
[No Abstract] [Full Text] [Related]
20. Effects of Corynebacterium parvum treatment and Toxoplasma gondii infection on macrophage-mediated cytostasis of tumour target cells.
Krahenbuhl JL; Lambert LH; Remington JS
Immunology; 1976 Dec; 31(6):837-46. PubMed ID: 992714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
